BCR-ABL plus acute myeloid leukemia: a rare and intriguing entity - a retrospective analysis of clinical and molecular features

被引：0
|
作者：
Neuendorff, N. R. [1 ]
Burmeister, T. [1 ,2 ]
Doerken, B. [1 ,2 ]
Westermann, J. [1 ,2 ]
机构：
[1] Charite, Klin Hamatol Onkol & Tumorimmunol, Campus Virchow Klinikum, Berlin, Germany
[2] Lab Berlin Charite Vivantes GmbH, Berlin, Germany
来源：
ONCOLOGY RESEARCH AND TREATMENT | 2016年 / 39卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
V357
引用
收藏
页码：111 / 111
页数：1
相关论文
共 50 条
  • [1] BCR-ABL-positive acute myeloid leukemia: a new entity? Analysis of clinical and molecular features
    Neuendorff, Nina Rosa
    Burmeister, Thomas
    Doerken, Bernd
    Westermann, Joerg
    ANNALS OF HEMATOLOGY, 2016, 95 (08) : 1211 - 1221
  • [2] BCR-ABL-positive acute myeloid leukemia: a new entity? Analysis of clinical and molecular features
    Nina Rosa Neuendorff
    Thomas Burmeister
    Bernd Dörken
    Jörg Westermann
    Annals of Hematology, 2016, 95 : 1211 - 1221
  • [3] Clinical applications of BCR-ABL molecular testing in acute leukemia
    Nashed, AL
    Rao, KW
    Gulley, ML
    JOURNAL OF MOLECULAR DIAGNOSTICS, 2003, 5 (02): : 63 - 72
  • [4] Molecular deregulations mediated by Bcr-Abl in chronic myeloid leukemia
    Chomel, JC
    Guilhot, F
    Tanzer, J
    Kitzis, A
    M S-MEDECINE SCIENCES, 1995, 11 (12): : 1669 - 1678
  • [5] Systematic analysis of BCR-ABL interactome in chronic myeloid leukemia
    Gregor, T.
    Rynes, J.
    Foldynova-Trantirkova, S.
    Mayer, J.
    Krejci, P.
    Trantirek, L.
    FEBS JOURNAL, 2017, 284 : 286 - 286
  • [6] Molecular breakpoint of BCR-ABL in chronic myeloid leukemia and imatinib response
    不详
    PHARMACOGENOMICS, 2010, 11 (09) : 1202 - 1203
  • [7] Acute Myeloid Leukemia with Concomitant BCR-ABL and NPM1 Mutations
    Mariotti, Benedetta
    Meconi, Federico
    Palmieri, Raffaele
    De Bellis, Eleonora
    Lavorgna, Serena
    Ottone, Tiziana
    Martini, Vincenza
    Lo-Coco, Francesco
    Cicconi, Laura
    CASE REPORTS IN HEMATOLOGY, 2019,
  • [8] NK cell recognition of BCR-ABL plus chronic myeloid leukemia (CML) in vivo
    Kijima, M. K. Mika
    Held, W. H. Werner
    ALLERGOLOGIE, 2011, 34 (02) : 90 - 90
  • [9] DEEP MOLECULAR RESPONSE TO NILOTINIB AS FIRST-LINE TREATMENT OF BCR-ABL plus CHRONIC MYELOID LEUKEMIA
    Castagnetti, F.
    Gugliotta, G.
    Breccia, M.
    Rossi, G.
    Stagno, F.
    Turri, D.
    Pregno, P.
    Tiribelli, M.
    Trabacchi, E.
    Martino, B.
    Carella, A. M.
    Isidori, A.
    Pierri, I.
    Salvucci, M.
    Specchia, G.
    Levato, L.
    Avanzini, P.
    Capalbo, S.
    Merli, A.
    Maino, E.
    Binotto, G.
    Bochicchio, M. T.
    Soverini, S.
    Cavo, M.
    Alimena, G.
    Martinelli, G.
    Saglio, G.
    Pane, F.
    Baccarani, M.
    Rosti, G.
    HAEMATOLOGICA, 2015, 100 : 55 - 55
  • [10] RARE BCR/ABL FUSION PROTEINS AND THEIR CLINICAL SIGNIFICANCE INTO PH plus ACUTE MYELOID LEUKEMIAS
    Piedimonte, M.
    Ottone, T.
    Alfonso, V.
    Ferrari, A.
    Conte, E.
    Divona, M.
    Bianchi, M. P.
    Ricciardi, M. R.
    Mirabilii, S.
    Licchetta, R.
    Falco, F.
    Campagna, A.
    Cicconi, L.
    Galassi, G.
    Pelliccia, S.
    Leporace, A.
    Lo Coco, F.
    Tafuri, A.
    HAEMATOLOGICA, 2017, 102 : 683 - 684
12345